Palomar Holdings, Inc.
NASDAQPLMR reports Q2 2026 results today having slipped 5% on the week to $136.11, underperforming most of its insurance peers, which fell 1–4% over the same stretch — while ACIC and ORI actually gained ground. The most telling signal heading into the print is how uniformly analysts have re-rated higher in recent weeks. JP Morgan lifted its target from $150 to…
PLMR cost-to-borrow surges to 0.46%, doubling week-over-week as short interest eases to 3.6% of free float.
Snapshot as of 6 Aug 2026
PLMR reports Q2 2026 results today having slipped 5% on the week to $136.11, underperforming most of its insurance peers, which fell 1–4% over the same stretch — while ACIC and ORI actually gained ground. The most…
Palomar Holdings is digesting a 6% pullback this week after its blistering 34% one-month run, with options traders now showing the most defensive tilt in recent memory even as Piper Sandler lifts its target to…
Palomar Holdings enters the week of July 8 having just posted one of its sharpest short-term rallies in recent memory — up 15% on the week and 34% over the past month — while the Street's most active analyst raises his…
Palomar Holdings enters mid-May under visible analyst pressure — two firms trimmed price targets in the past three days, the stock is down 15% over the past month, and options traders are as bullish as they have been…
Palomar Holdings enters its Q1 2026 earnings report today having shed more than 10% in the past week alone, arriving at $110.75 with the price action doing far more talking than any bear thesis in the lending…
Palomar Holdings walked into its Q1 2026 earnings report carrying a 12% weekly loss. It walked out with a beat and a $200 million buyback. That combination is the central tension this week: the underlying business…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PLMR — free to start on ORTEX.
Sign up for free →Open PLMR on ORTEX